KR101874467B1 - Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component - Google Patents
Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component Download PDFInfo
- Publication number
- KR101874467B1 KR101874467B1 KR1020180024517A KR20180024517A KR101874467B1 KR 101874467 B1 KR101874467 B1 KR 101874467B1 KR 1020180024517 A KR1020180024517 A KR 1020180024517A KR 20180024517 A KR20180024517 A KR 20180024517A KR 101874467 B1 KR101874467 B1 KR 101874467B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- skin
- lotion
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 239000000284 extract Substances 0.000 title claims abstract description 28
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 230000037303 wrinkles Effects 0.000 title claims abstract description 18
- 241000767510 Protaetia brevitarsis Species 0.000 title abstract 4
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 13
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 13
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 13
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims abstract description 9
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000006210 lotion Substances 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- 230000035764 nutrition Effects 0.000 claims description 5
- 230000000475 sunscreen effect Effects 0.000 claims description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 claims description 2
- 239000008269 hand cream Substances 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 2
- 230000003013 cytotoxicity Effects 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- -1 glycerol aliphatic ester Chemical class 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003817 vacuum liquid chromatography Methods 0.000 description 3
- FSNCEEGOMTYXKY-JTQLQIEISA-N (3s)-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylic acid Chemical compound N1C2=CC=CC=C2C2=C1CN[C@H](C(=O)O)C2 FSNCEEGOMTYXKY-JTQLQIEISA-N 0.000 description 2
- ZUPHXNBLQCSEIA-UHFFFAOYSA-N 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid Natural products N1C2=CC=CC=C2C2=C1C(C)NC(C(O)=O)C2 ZUPHXNBLQCSEIA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ATDWJOOPFDQZNK-UHFFFAOYSA-N N-acetyltyramine Chemical compound CC(=O)NCCC1=CC=C(O)C=C1 ATDWJOOPFDQZNK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000002034 butanolic fraction Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- ZUPHXNBLQCSEIA-HQJQHLMTSA-N (1r,3s)-1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylic acid Chemical compound N1C2=CC=CC=C2C2=C1[C@@H](C)N[C@H](C(O)=O)C2 ZUPHXNBLQCSEIA-HQJQHLMTSA-N 0.000 description 1
- ZUPHXNBLQCSEIA-CPCISQLKSA-N (1s,3s)-1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylic acid Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C)N[C@H](C(O)=O)C2 ZUPHXNBLQCSEIA-CPCISQLKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XNQLMEKQPNBFCY-LSJOCFKGSA-N (3S)-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid Natural products C1=CC=C2[C@@H]3C[C@@H](C(=O)[O-])[NH2+]C[C@@H]3NC2=C1 XNQLMEKQPNBFCY-LSJOCFKGSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100191768 Caenorhabditis elegans pbs-4 gene Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000000719 MTS assay Methods 0.000 description 1
- 231100000070 MTS assay Toxicity 0.000 description 1
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical class CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000002737 cell proliferation kit Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XLUAWXQORJEMBD-YUMQZZPRSA-N cyclo(L-Pro-L-Val) Chemical compound O=C1[C@H](C(C)C)NC(=O)[C@@H]2CCCN21 XLUAWXQORJEMBD-YUMQZZPRSA-N 0.000 description 1
- XLUAWXQORJEMBD-UHFFFAOYSA-N cyclo-L-Val-L-Pro Natural products O=C1C(C(C)C)NC(=O)C2CCCN21 XLUAWXQORJEMBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000005218 dimethyl ethers Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- UTWGRMYWDUMKNY-UHFFFAOYSA-N indole-1-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)C=CC2=C1 UTWGRMYWDUMKNY-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 꽃벵이 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin wrinkles or skin moisturizing, comprising as an active ingredient a flower bud extract or a compound isolated therefrom.
피부는 외부의 환경과 항상 접하고 있는 기관으로 주로 외부의 물리적 손상 및 화학물질로부터 인체를 보호하고, 세균, 곰팡이, 바이러스 등이 피부로 침범하는 것을 방지하며, 수분 손실을 막는 보호장벽 역할을 한다. 피부의 구조를 보면 표피, 진피, 피하지방의 3개 층으로 구성되고 표피는 3개 층 중 가장 얇은 층으로 피부의 보습 및 보호를 담당하는 중요한 기능을 한다. 특히 표피의 각질층에 존재하는 수분에 의하여 피부가 탄력 있고 부드럽게 되는데, 각질층의 탄력이 유지되려면 10% 이상의 수분함유가 필수적인 것으로 알려져 있다(O. K. Jacobi, Proc. Sci. Sec. Toilet Goods Assoc. 1959, 31, 22).Skin is an organ that is always in contact with the outside environment. It protects the body from external physical damage and chemical substances, prevents bacteria, fungi, viruses from invading the skin, and acts as a protection barrier against moisture loss. Skin structure consists of three layers: epidermis, dermis, and subcutaneous fat. The epidermis is the thinnest of the three layers, which plays an important role in moisturizing and protecting the skin. In particular, the skin is elastic and softened by the water present in the stratum corneum of the epidermis, and it is known that the water content of 10% or more is essential for the elasticity of the stratum corneum to be maintained (OK Jacobi, Proc. , 22).
최근 들어, 환경오염 등의 이유로 강한 자외선에 노출되는 경우가 많아졌고, 이에 의한 피부의 수분 손실이 증가하면서 피부 노화가 가속화되고, 피부의 손상에 의한 관련 질병의 발병률이 증가함에 따라, 자외선에 노출된 피부의 보습 유지 및 주름개선 효과를 오랫동안 지속시켜주는 조성물에 대한 요구는 점점 증가하는 추세이다. Recently, exposure to strong ultraviolet rays has become more frequent due to environmental pollution, skin aging has accelerated due to increase in moisture loss of the skin, and as the incidence of related diseases caused by skin damage has increased, exposure to ultraviolet There is an increasing demand for a composition that maintains the moisturizing maintenance and wrinkle-reducing effect of the skin for a long time.
한편, 꽃벵이는 흰 점박이 꽃 무지의 유충으로, 흰 점박이 꽃 무지는 몸길이는 17~22mm이며 몸은 광택이 강한 녹갈색이나 구릿빛 또는 붉은빛을 띠는데 녹색, 남색, 흑남색, 흑자색 등의 변이도 있다. 후경절 안쪽의 털은 회갈색이며, 중흉돌기의 끝은 은행모양이고, 딱지날개의 끝은 뾰족하게 돌출하였다. 수컷의 복부복판은 길이로 패였다. 교미구는 가는 직선형이며, 내판은 좁고 긴데 끝에 둥글게 돌출한 부분이 있다.On the other hand, the flower is a larva of white spotted flower, the white spotted flower is 17 ~ 22mm in length, and the body has green, brown or red light with strong gloss, and there are variations such as green, indigo, . The hair on the inside of the posterior medulla was grayish brown, the tip of the barycic auricle was bank shaped, and the tip of the scab wing protruded sharply. The abdomen of the male was decapitated in length. The mating hole is thin straight, the inner plate is narrow and long, and there is a part protruding round at the end.
지금까지 알려진 흰점박이꽃무지 관련 기술의 일례로는 한국식품영양과학회지(J Korean Soc Food Sci Nutr 41(1), 41~48,2012)에 '흰점박이꽃무지 함유 음료의 in vitro 항산화 관련 생리활성효능 및 안전성 검증'이 개시되어 있으며, 한국등록특허 제0414187호에 흰점박이꽃무지 추출물 및 이의 용도가 개시되어 있으나, 본 발명의 꽃벵이 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물에 대해서는 개시된 바 없다.One example of the technique related to the white spotted flowers known so far is the 'in vitro antioxidative physiology related to the white spotted flower free drink' in the Korean Journal of Food Science and Nutrition (J Korean Soc Food Sci Nutr 41 (1), 41-48,2012) Active ingredient and its safety has been disclosed in Korean Patent Publication No. 0414187. However, the present invention is not limited to the use of the extract of the present invention or the compound isolated therefrom as an active ingredient, No cosmetic composition for improving wrinkles or moisturizing skin has been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명은 꽃벵이 추출물 또는 이로부터 분리된 화학식 1 내지 5 중에서 선택된 하나 이상의 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물을 제공하고, 상기 유효성분이 세포 외 기질과 기저막의 분해에 관여하는 콜라겐 분해 효소(MMPs; matrix metalloproteinases)인 MMP-1의 발현량을 감소시키는 것과, 피부 보습 기능과 피부 장벽 손상을 방지하는 히알루론산의 함량을 증진시키는 것을 확인함으로써, 본 발명을 완성하였다.The present invention provides a cosmetic composition for skin wrinkle improvement or skin moisturizing which comprises as an active ingredient at least one compound selected from
상기 목적을 달성하기 위하여, 본 발명은 꽃벵이 추출물 또는 이로부터 분리된 화학식 1 내지 5 중에서 선택된 하나 이상의 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for improving skin wrinkles or skin moisturizing, comprising as an active ingredient a flower bud extract or at least one compound selected from the following formulas (1) to (5) isolated therefrom.
본 발명은 꽃벵이 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 조성물에 관한 것으로, 본 발명의 유효성분은 세포 독성이 거의 없으며, 피부 주름 개선과 피부 보습에 효과가 있는 것이다. 따라서 본 발명의 조성물을 피부 주름 개선 또는 피부 보습용 화장료에 적용할 수 있다.The present invention relates to a composition for improving skin wrinkles or skin moisturizing composition containing a flower bud extract or a compound isolated therefrom as an active ingredient. The effective ingredient of the present invention has little cytotoxicity, and is effective for improving skin wrinkles and skin moisturizing . Therefore, the composition of the present invention can be applied to a cosmetic for improving skin wrinkles or skin moisturizing.
도 1은 본 발명의 꽃벵이 추출물(A) 및 이로부터 분리된 화학식 1~5의 화합물(B)의 농도별 처리에 따른 세포 생존율(%)을 분석한 결과이다.
도 2는 UV 조사 및 본 발명의 꽃벵이 추출물(A) 및 이로부터 분리된 화학식 1~5의 화합물(B)의 농도별 처리에 따른 MMP-1 단백질의 발현량 변화를 분석한 결과이다. Control은 아무것도 처리하지 않는 음성대조군이고, UVB는 본 발명의 본 발명의 꽃벵이 추출물 및 이로부터 분리된 화합물 1~5는 처리하지 않고, 자외선만을 조사한 대조군이다.
도 3은 UV 조사 및 본 발명의 꽃벵이 추출물(A) 및 이로부터 분리된 화학식 1~5의 화합물(B)의 농도별 처리에 따른 히알루론산(HA) 변화를 분석한 결과이다. Control은 아무것도 처리하지 않는 음성대조군이고, UVB는 본 발명의 본 발명의 꽃벵이 추출물 및 이로부터 분리된 화합물 1~5는 처리하지 않고, 자외선만을 조사한 대조군이다.FIG. 1 shows the results of analysis of the cell viability (%) according to the treatment of the concentration of the flower bud extract (A) of the present invention and the compound (B) of the
FIG. 2 shows the results of analysis of changes in the expression level of MMP-1 protein according to the UV irradiation and treatment of the extract of the present invention (A) and the compound (B) of the
FIG. 3 shows the results of analysis of hyaluronic acid (HA) changes according to UV irradiation and treatment of the concentration of the compound (B) of the present invention (A) and the compound (B) isolated therefrom. Control is a negative control group that does nothing and UVB is a control group in which the present flower ear extract of the present invention and
본 발명은 꽃벵이 추출물 또는 이로부터 분리된 하기 화학식 1 내지 5 중에서 선택된 하나 이상의 화합물을 유효성분으로 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin wrinkles or skin moisturizing, comprising as an active ingredient a flower bud extract or at least one compound selected from the following formulas (1) to (5) isolated therefrom.
상기 꽃벵이 추출물은 하기의 단계를 포함하는 방법에 의해 제조할 수 있으나, 이에 한정하지 않는다:The flower bud extract can be prepared by a method including, but not limited to, the following steps:
(1) 꽃벵이 건조 분말에 추출용매를 가하여 추출하는 단계;(1) extracting a dry powder of a flower bud by adding an extraction solvent;
(2) 단계 (1)의 추출물을 여과하는 단계; 및 (2) filtering the extract of step (1); And
(3) 단계 (2)의 여과한 추출물을 감압 농축하고 건조하여 추출물을 제조하는 단계. (3) The step of extracting the filtered extract of step (2) by concentration under reduced pressure and drying.
상기 단계 (1)에서 추출용매는 물, C1~C4의 저급 알코올 또는 이들의 혼합물 중에서 선택하는 것이 바람직하며, 더 바람직하게는 에탄올이고, 더욱더 바람직하게는 70%(v/v) 에탄올이지만 이에 한정하지 않는다.In step (1), the extraction solvent is preferably selected from water, a C 1 -C 4 lower alcohol or a mixture thereof, more preferably ethanol, even more preferably 70% (v / v) ethanol But is not limited thereto.
상기 제조방법에 있어서, 추출방법은 여과법, 열수 추출, 침지 추출, 환류 냉각 추출 및 초음파 추출 등의 당 업계에 공지된 모든 통상적인 방법을 이용할 수 있다. 상기 추출용매는 건조된 꽃벵이 중량의 1~20배 첨가하여 추출하는 것이 바람직하며, 더 바람직하게는 5~15배 첨가하는 것이다. 추출온도는 4 내지 50℃인 것이 바람직하나 이에 한정하지 않는다. 또한, 추출시간은 0.5~10시간인 것이 바람직하며, 0.5~5시간이 더욱 바람직하고, 1시간이 가장 바람직하나 이에 한정하지 않는다. 상기 방법에 있어서, 단계 (3)의 감압농축은 진공 감압 농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무 건조 또는 동결 건조하는 것이 바람직하나 이에 한정하지 않는다.In the above production method, any conventional method known in the art such as filtration, hot water extraction, immersion extraction, reflux cooling extraction, and ultrasonic extraction may be used. The extraction solvent is preferably added by 1 to 20 times the weight of the dried flower bud, more preferably 5 to 15 times the weight of the dried flower bud. The extraction temperature is preferably 4 to 50 DEG C, but is not limited thereto. The extraction time is preferably 0.5 to 10 hours, more preferably 0.5 to 5 hours, most preferably 1 hour, but not always limited thereto. In the above method, it is preferable to use a vacuum decompression concentrator or a vacuum rotary evaporator for the decompression concentration in the step (3), but it is not limited thereto. The drying is preferably performed under reduced pressure, vacuum drying, boiling, spray drying or freeze drying, but not always limited thereto.
본 발명에서 주름 생성은 콜라겐의 감소로 인해 발생하는 것이며, 상기 콜라겐의 감소는 과도한 산화 스트레스나 자외선 조사가 원인일 수 있다.In the present invention, wrinkle formation is caused by reduction of collagen, and reduction of the collagen may be caused by excessive oxidative stress or ultraviolet irradiation.
상기 꽃벵이 추출물 또는 이로부터 분리된 상기 화학식 1 내지 5 중에서 선택된 하나 이상의 화합물은 MMP-1 단백질의 발현량을 감소시키며, 히알루론산의 함량을 증가시킬 수 있다.The above-mentioned flower bud extract or at least one compound selected from the above-mentioned formulas (1) to (5) from which the extract is isolated may reduce the expression amount of MMP-1 protein and increase the content of hyaluronic acid.
본 발명의 일 구현 예에 따른 화장료 조성물은 피부 외용 연고, 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징 폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.The cosmetic composition according to one embodiment of the present invention may be used as an external ointment for skin, a cream, a softening agent, a nutritional lotion, a pack, an essence, a hair tonic, a shampoo, a rinse, a hair conditioner, a hair treatment, a gel, a skin lotion, Toner, Astringent, Lotion, Milk Lotion, Moisture Lotion, Nutrition Lotion, Massage Cream, Nourishing Cream, Moisture Cream, Hand Cream, Foundation, Nutrition Essence, Sunscreen, Soap, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion and Body And a cleanser. However, the present invention is not limited thereto. The cosmetic composition comprising each of these formulations may contain various bases and additives necessary for formulation of the formulation, and the kinds and amounts of these ingredients can be easily selected by those skilled in the art.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, a cream or a gel, an animal fiber, a plant fiber, a wax, a paraffin, a starch, a tragacanth, a cellulose derivative, a polyethylene glycol, a silicone, a bentonite, Etc. may be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, Propellants such as hydrocarbons, propane-butanes or dimethyl ethers.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or an emulsion, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a cleansing agent containing an interfacial active agent, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, acethionate, imidazolinium derivative, methyltaurate, sarcosinate , Fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linolenic derivative or ethoxylated glycerol fatty acid ester.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.
The cosmetic composition of the present invention may further contain an excipient including a fluorescent substance, a fungicide, a hygroscopic substance, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen, a vitamin, .
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.
실시예Example 1. One. 꽃벵이Flower bud 추출물의 제조 및 5종 화합물의 분리 Preparation of Extracts and Isolation of Five Compounds
꽃벵이(흰점박이꽃무지 유충)(5.17kg)를 1%(v/v) 아세트산이 포함된 에탄올로 추출하여(5ℓ×4) 에탄올 추출액을 얻고, 에탄올 추출액을 감압증류하여 갈색을 띠는 에탄올 추출물을 968.0g을 획득하였다. The ethanol extract (5 L × 4) was extracted with ethanol containing 1% (v / v) acetic acid (5.17 kg) of a flower bud (white spotted flower larva), and the ethanol extract was distilled under reduced pressure to obtain brown ethanol 968.0 g of the extract was obtained.
상기 획득한 에탄올 추출물을 물에 현탁하고, n-헥산, 에틸아세테이트, 부탄올로 순차적으로 분획하여 n-헥산 분획물(400g, PBS-1), 에틸아세테이트 분획물(10.0g, PBS-2), 부탄올 분획물(47.3g, PBS-3)과 물 잔사 분획물(510.0g, PBS-4)을 획득하였다. 에틸아세테이트 분획물(PBS-2)은 헥산/에틸아세테이트 5:1, 4:1, 2:1 및 1:1(v:v); 헥산/에틸 아세테이트/메탄올 1/1/0.2(v:v:v); 클로로포름/메탄올 7:1(v:v); 클로로포름/메탄올 5:1(v:v)의 농도 구배 용리 조건 및 메탄올 세척조건으로 VLC(vacuum liquid chromatography)를 수행하여 7개의 소 분획물을 획득하였다(PBS-2a~PBS-2g). 소 분획물 PBS-2d(2g)은 30~70%(v/v)의 메탄올 수용액 농도 구배를 갖는 조건에서 Kinetex Biphenyl 칼럼을 이용한 HPLC(헥산/에틸 아세테이트/메탄올 1:1:0.2(v:v:v)의 용리조건)를 통해 cyclo(L-Val-L-Pro) (t R, 23min, 21 mg)(화학식 4의 화합물) 및 N-acetyltyramine (t R, 28min, 115mg)(화학식 5의 화합물);을 획득하였다. The obtained ethanol extracts were suspended in water and sequentially fractionated with n -hexane, ethyl acetate and butanol. The n -hexane fraction (400 g, PBS-1), the ethyl acetate fraction (10.0 g, PBS-2) and the butanol fraction (47.3 g, PBS-3) and water residue fraction (510.0 g, PBS-4). The ethyl acetate fraction (PBS-2) was eluted with hexane / ethyl acetate 5: 1, 4: 1, 2: 1 and 1: 1 (v: v); Hexane / ethyl acetate /
부탄올 분획물(47.8g, PBS-3)은 9:1, 7:1, 6:1, 4:1, 2:1 (v:v) 클로로포름/메탄올(v:v)의 용리조건을 갖는 VLC를 수행하여 6개의 소 분획물(PBS-3a~PBS-3-f)로 분획 되었다. 또한, PBS-3f 소 분획물(20g)로부터 20~50%(v/v)의 농도 구배를 갖는 메탄올 수용액 용리조건을 이용하여 MPLC를 통해 3개의 소 분획물을 획득하였다(PBS-3f-a~PBS-3f-c). The butanol fraction (47.8 g, PBS-3) was eluted with VLC having elution conditions of 9: 1, 7: 1, 6: 1, 4: 1, 2: 1 (v: v) chloroform / methanol (v: And fractionated into six small fractions (PBS-3a to PBS-3-f). From the PBS-3f fraction (20 g), three small fractions were obtained by MPLC using a methanol aqueous solution elution condition having a concentration gradient of 20 to 50% (v / v) (PBS-3f-a to PBS -3f-c).
(1R,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (t R, 58min, 15mg)(화학식 1의 화합물); (1 R, 3 S) -1 -methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (t R, 58min, 15mg) ( compounds of formula (1));
(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (t R, 57min, 20mg)(화학식 2의 화합물); (1 S, 3 S) -1 -methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (t R, 57min, 20mg) ( compound of formula (2));
(3S)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (t R, 53min, 25mg)는 10~40%(v/v)의 메탄올 수용액 농도구배를 갖는 Kinetex Biphenyl 칼럼을 이용한 HPLC를 통해 PBS-3f-b (2g) 소 분획물로부터 분리되었다. methyl 9H-pyrido[3,4-β]indole-1-carboxylate (t R, 45min, 10mg)(화학식 3의 화합물)는 50~70%(v/v)의 메탄올 수용액 농도구배를 갖는 조건에서 Kinetex Biphenyl 칼럼을 이용한 HPLC를 통해 PBS-3a(100g) 소 분획물로부터 분리되었다.
(3 S) -1,2,3,4-tetrahydro- β-carboline-3-carboxylic acid (t R, 53min, 25mg) is 10 ~ 40% (v / v ) Kinetex Biphenyl having a concentration gradient of aqueous methanol solution The column was separated from the PBS-3f-b (2 g) fraction by HPLC. methyl 9 H -pyrido [3,4-β ] indole-1-carboxylate (t R, 45min, 10mg) in a condition having a concentration gradient of aqueous methanol solution (the compound of formula 3) is 50 ~ 70% (v / v ) Were separated from the PBS-3a (100 g) fraction by HPLC using a Kinetex Biphenyl column.
실시예 2. 꽃벵이 추출물 또는 이로부터 분리된 화학식 1~5의 화합물 처리에 따른 세포 생존율 분석 Example 2. Cell survival analysis according to the treatment of the compounds of the
HaCaT 세포(사람 각질형성 세포주)는 37℃, 5%의 CO2 조건으로, 10%의 FBS(Fetal bovine serum)과 1%의 페니실린-스트렙토마이신(PS, Gibco)이 함유된DMEM(Dulbecco's Modified Eagle Medium)에서 배양하였다. HaCaT cells (human keratinocyte cell line) is 37 ℃, the CO 2 conditions of 5%, 10% of FBS (Fetal bovine serum) and 1% penicillin-streptomycin (PS, Gibco) Dulbecco (this contained DMEM's Modified Eagle Medium).
상기 배양한 HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 각각의 시료를 농도별로 희석하여 처리하고 MTS 어세이(CellTiter Aqueous One Solution Cell proliferation assay kit 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophynyl)-2H-tetrazolium, inner salt; MTS, Promega Co. Madison, WI, USA) 기법으로 세포 생존능을 490nm에서 마이크로플레이트 리더(Molecular Devices, Sunnyvale, CA, USA)로 측정하여 시험하였다. Each sample was diluted by concentration for 24 hours in the cultured HaCaT cells (human keratinocyte line), and the cells were treated with MTS assay (CellTiter Aqueous One Solution Cell proliferation assay kit 3- (4,5-dimethylthiazol-2-yl) Cell viability was measured at 490 nm using a microplate reader (Molecular Devices, Sunnyvale, Calif.) At 490 nm by the method of MTS, Promega Co., Madison, Wis., USA) , CA, USA).
그 결과 도 1에 개시한 바와 같이, 본 발명의 꽃벵이 추출물, 이로부터 분리한 화학식 1~5의 화합물을 처리하여도 세포 생존율(%)이 아무것도 처리하지 않은 대조군을 기준으로 거의 변화가 없어 세포독성이 거의 없다는 것을 확인하였다.
As a result, as shown in Fig. 1, even when the flower bud extract of the present invention and the compounds of the
실시예Example 3. 3. MMPMMP -1과 히알루론산(-1 and hyaluronic acid ( HyaluronicHyaluronic Acid; HA)의 발현량 분석 Acid; HA)
상기 HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 각각의 시료를 처리하고 자외선(UV Crosslinker, Ultra Lum)을 20 mJ/cm2로 30분간 조사한 후, 배양물의 상등액을 수집하여 MMP-1 ELISA 키트(R&D Systems, Inc., Minneapolis, MN, USA)를 이용하여 MMP-1의 발현량을 측정하였고, Hyaluronic acid ELISA 키트(R&D Systems, Inc., Minneapolis, MN, USA)를 이용하여 HA의 함량을 측정하였다. 반응물은 흡광 어세이를 수행하였다.Each sample was treated with HaCaT cells (human keratinocyte line) for 24 hours, irradiated with ultraviolet light (UV Crosslinker, Ultra Lum) at 20 mJ / cm 2 for 30 minutes, and then the supernatant of the culture was collected and the MMP-1 ELISA kit (R & D Systems, Inc., Minneapolis, MN, USA), and the content of HA was measured using a Hyaluronic acid ELISA kit (R & D Systems, Respectively. The reactants were subjected to an absorbance assay.
그 결과 도 2 및 도 3에 개시한 바와 같이, 자외선 조사에 의해, MMP-1의 발현량이 급격하게 증가하였고, 히알루론산의 함량은 감소하였으나, 자외선 조사 및 본 발명의 꽃벵이 추출물 및 화학식 1~5의 화합물을 농도별로 처리한 각각의 실험군에서는 농도 의존적으로, MMP-1의 발현량이 현저하게 감소하였고(도 2), 자외선 조사군에서의 히알루론산의 함량에 비해 증가한 것을 확인하였다(도 3).As a result, as shown in FIG. 2 and FIG. 3, the amount of MMP-1 expression increased sharply and the content of hyaluronic acid decreased by ultraviolet irradiation. However, when irradiated with ultraviolet rays, 5, the expression level of MMP-1 was remarkably decreased (FIG. 2) in a concentration-dependent manner, and it was confirmed that the amount of MMP-1 was increased compared with the content of hyaluronic acid in the ultraviolet irradiation group (FIG. 3) .
Claims (5)
[화학식 1]
[화학식 2]
[화학식 3]
[화학식 4]
[화학식 5]
A cosmetic composition for improving skin wrinkles or skin moisturizing, comprising as an active ingredient at least one compound selected from the following Formulas (1) to (5), wherein the extract is:
[Chemical Formula 1]
(2)
(3)
[Chemical Formula 4]
[Chemical Formula 5]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180024517A KR101874467B1 (en) | 2018-02-28 | 2018-02-28 | Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180024517A KR101874467B1 (en) | 2018-02-28 | 2018-02-28 | Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170045222A Division KR101907850B1 (en) | 2017-04-07 | 2017-04-07 | Composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101874467B1 true KR101874467B1 (en) | 2018-07-05 |
Family
ID=62920602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180024517A KR101874467B1 (en) | 2018-02-28 | 2018-02-28 | Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101874467B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210076247A (en) * | 2019-12-13 | 2021-06-24 | 계명대학교 산학협력단 | Composition for Improving Wrinkle, Wound Healing, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Protaetia brevitarsis |
KR20220038851A (en) | 2020-09-21 | 2022-03-29 | 주식회사 서미바이오 | Method for manufacturing cream-type cosmetic product containing grub powder |
KR20220095649A (en) * | 2020-12-30 | 2022-07-07 | (주) 명품 | Cosmetic composition comprising insect extracts |
KR20230130489A (en) | 2022-03-03 | 2023-09-12 | 주식회사 케이와이코스메틱 | Cosmetic materials for skin-whitening and anti-wrinkle, Cosmetics containing the same, and Manufacturing method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101723206B1 (en) | 2016-12-07 | 2017-04-05 | 전성보 | Pills for health supplement food comprising extracts of protaetia brebitarsis larba and manufacturing method for the same |
-
2018
- 2018-02-28 KR KR1020180024517A patent/KR101874467B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101723206B1 (en) | 2016-12-07 | 2017-04-05 | 전성보 | Pills for health supplement food comprising extracts of protaetia brebitarsis larba and manufacturing method for the same |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210076247A (en) * | 2019-12-13 | 2021-06-24 | 계명대학교 산학협력단 | Composition for Improving Wrinkle, Wound Healing, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Protaetia brevitarsis |
KR102308726B1 (en) * | 2019-12-13 | 2021-10-06 | 계명대학교 산학협력단 | Composition for Improving Wrinkle, Wound Healing, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Protaetia brevitarsis |
KR20220038851A (en) | 2020-09-21 | 2022-03-29 | 주식회사 서미바이오 | Method for manufacturing cream-type cosmetic product containing grub powder |
KR20220095649A (en) * | 2020-12-30 | 2022-07-07 | (주) 명품 | Cosmetic composition comprising insect extracts |
KR102579725B1 (en) * | 2020-12-30 | 2023-09-18 | (주) 명품 | Cosmetic composition comprising insect extracts |
KR20230130489A (en) | 2022-03-03 | 2023-09-12 | 주식회사 케이와이코스메틱 | Cosmetic materials for skin-whitening and anti-wrinkle, Cosmetics containing the same, and Manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101874467B1 (en) | Cosmetic composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component | |
KR20130023326A (en) | Cosmetic composition containing the sargassum fulvellum, gelidium cartilagineum and hixikia fusiforme okamura extracts | |
KR101908077B1 (en) | Cosmetic composition for whitening, antiaging or skin wrinkle containing natural oriental medicine extracts | |
KR101860352B1 (en) | A cosmetic composition for treating demodex infestations comprising extract of artemisia apiaceae | |
KR20130023325A (en) | Cosmetic composition containing the fraxinus rhynchophylla extracts | |
KR101907850B1 (en) | Composition for improving skin wrinkle or skin moisturing comprising Protaetia brevitarsis extract or compound isolated therefrom as effective component | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR20210095341A (en) | A composition comprising spirulina extract for skin regeneration | |
KR20140137540A (en) | Method for preparing mugwort extract and cosmetic composition comprising mugwort extract prepared therefrom | |
KR102031288B1 (en) | A cosmetic composition comprising cabbage cultiva rfermented extract | |
KR20200064899A (en) | Cosmetic Composition Containing Fraction of Extract Derived from Passiflora edulis for Skin-Whitening | |
KR102041860B1 (en) | Composition for improving skin wrinkle or skin moisturizing comprising Gryllus bimaculatus extract as effective component | |
KR102056263B1 (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR102014395B1 (en) | Cosmetic compositions comprising Nigella sativa | |
KR102068736B1 (en) | A cosmetic composition for anti-aging comprising extract of coffee grounds | |
KR102455132B1 (en) | Cosmetic composition containing lemon myrtle extract and its manufacturing method | |
KR102002169B1 (en) | Cosmetic composition for improving skin wrinkle or skin moisturizing comprising Allomyrina dichotoma larva extract as effective component | |
KR101949956B1 (en) | Cosmetic composition for improving skin wrinkle comprising Oxya chinensis sinuosa extract or compound isolated from the extract as effective component | |
KR20130023324A (en) | Cosmetic composition comprising of the mixed herb fermentation extracts | |
KR101971257B1 (en) | A cosmetic composition comprising tenebrio molitor extract | |
KR102031289B1 (en) | A cosmetic composition comprising flankton extract for blue light interception | |
KR20040087644A (en) | Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening | |
JP2001354540A (en) | Skin care preparation | |
KR101926179B1 (en) | Cosmetic composition containing canavalia lineata extract for moisturizing and anti-wrinkle effects on the skin | |
KR20160055118A (en) | Cosmetic composition comprising of the mixed herb fermentes and preparation method of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant |